相关实验视频

Updated: May 25, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.2K

在Impella支持期间使用纳法莫斯塔特梅西拉酸进行抗凝固治疗:一个案例报告

Makiko Nakamura1, Teruhiko Imamura1, Yuki Hida1

  • 1The Second Department of Internal Medicine, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.

Medicina (Kaunas, Lithuania)
|February 26, 2025
PubMed
概括

在接受Impella支持的患者中,纳法莫斯塔特甲基酸盐 (NM) 有效地预防了血栓形成,并改善了血栓缩. 仔细监测低血症对于这种抗凝血策略至关重要.

关键词:
在ECMO中,可以使用ECMO.在 ENaC 中.案例报告案例报告过低血症是什么情况血小板细胞减少症 (Thrombocytopenia) 是一种

更多相关视频

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

1.8K
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.5K

相关概念视频

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
592